Trial Profile
Effects of Anamorelin on Cancer-Related-Fatigue in Patients With Advanced Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2023
Price :
$35
*
At a glance
- Drugs Anamorelin (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- 10 May 2023 Planned End Date changed from 28 Feb 2023 to 28 Feb 2026.
- 18 May 2022 Planned End Date changed from 28 Feb 2022 to 28 Feb 2023.
- 06 Jan 2022 Planned End Date changed from 28 Feb 2020 to 28 Feb 2022.